BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 30690078)

  • 1. UBE2S mediates tumor progression via SOX6/β-Catenin signaling in endometrial cancer.
    Lin M; Lei T; Zheng J; Chen S; Du L; Xie H
    Int J Biochem Cell Biol; 2019 Apr; 109():17-22. PubMed ID: 30690078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBE2S interacting with TRIM21 mediates the K11-linked ubiquitination of LPP to promote the lymphatic metastasis of bladder cancer.
    Xiao K; Peng S; Lu J; Zhou T; Hong X; Chen S; Liu G; Li H; Huang J; Chen X; Lin T
    Cell Death Dis; 2023 Jul; 14(7):408. PubMed ID: 37422473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAP4K4 and WT1 mediate SOX6-induced cellular senescence by synergistically activating the ATF2-TGFβ2-Smad2/3 signaling pathway in cervical cancer.
    Zheng H; Liu M; Shi S; Huang H; Yang X; Luo Z; Song Y; Xu Q; Li T; Xue L; Lu F; Wang J
    Mol Oncol; 2024 May; 18(5):1327-1346. PubMed ID: 38383842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UBE2S targets RPL26 for ubiquitination and degradation to promote non-small cell lung cancer progression via regulating c-Myc.
    Gong D; Rao X; Min Z; Liu X; Xin H; Zhou P; Yang L; Li D
    Am J Cancer Res; 2023; 13(8):3705-3720. PubMed ID: 37693154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. As a potential predictor of pan-cancer,
    Yue H; Wang J; Hou S; Zhang M
    Future Oncol; 2023 Sep; 19(29):1973-1990. PubMed ID: 37791471
    [No Abstract]   [Full Text] [Related]  

  • 6. Ube2S regulates Wnt/β-catenin signaling and promotes the progression of non-small cell lung cancer.
    Qin Y; Du J; Fan C
    Int J Med Sci; 2020; 17(2):274-279. PubMed ID: 32038111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Expression of
    Zou R; Xu H; Li F; Wang S; Zhu L
    DNA Cell Biol; 2021 Jan; 40(1):36-60. PubMed ID: 33180631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UBE2S interacting with TRIM28 in the nucleus accelerates cell cycle by ubiquitination of p27 to promote hepatocellular carcinoma development.
    Zhang RY; Liu ZK; Wei D; Yong YL; Lin P; Li H; Liu M; Zheng NS; Liu K; Hu CX; Yang XZ; Chen ZN; Bian H
    Signal Transduct Target Ther; 2021 Feb; 6(1):64. PubMed ID: 33589597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ube2s-stabilized β-catenin protects against myocardial ischemia/reperfusion injury by activating HIF-1α signaling.
    Chen X; Wang C; Yang P; Shi L; Wang H
    Aging (Albany NY); 2020 Apr; 12(7):5716-5732. PubMed ID: 32250966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic Activities Of UBE2S Mediated By VHL/HIF-1α/STAT3 Signal Via The Ubiquitin-Proteasome System In PDAC.
    Wang L; Liang Y; Li P; Liang Q; Sun H; Xu D; Hu W
    Onco Targets Ther; 2019; 12():9767-9781. PubMed ID: 31814735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UBE2S activates NF-κB signaling by binding with IκBα and promotes metastasis of lung adenocarcinoma cells.
    Ho JY; Lu HY; Cheng HH; Kuo YC; Lee YA; Cheng CH
    Cell Oncol (Dordr); 2021 Dec; 44(6):1325-1338. PubMed ID: 34582005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin chain-elongating enzyme UBE2S activates the RING E3 ligase APC/C for substrate priming.
    Martinez-Chacin RC; Bodrug T; Bolhuis DL; Kedziora KM; Bonacci T; Ordureau A; Gibbs ME; Weissmann F; Qiao R; Grant GD; Cook JG; Peters JM; Wade Harper J; Emanuele MJ; Brown NG
    Nat Struct Mol Biol; 2020 Jun; 27(6):550-560. PubMed ID: 32393902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse roles of UBE2S in cancer and therapy resistance: Biological functions and mechanisms.
    Zhang M; Wang J; Zhang Z; Guo Y; Lou X; Zhang L
    Heliyon; 2024 Jan; 10(2):e24465. PubMed ID: 38312603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Significance of SOX10 Expression in Human Pathology.
    Bahmad HF; Thiravialingam A; Sriganeshan K; Gonzalez J; Alvarez V; Ocejo S; Abreu AR; Avellan R; Arzola AH; Hachem S; Poppiti R
    Curr Issues Mol Biol; 2023 Dec; 45(12):10131-10158. PubMed ID: 38132479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of PI3K/AKT/mTOR signaling axis by UBE2S inhibits autophagy leading to cisplatin resistance in ovarian cancer.
    Zhang M; Wang J; Guo Y; Yue H; Zhang L
    J Ovarian Res; 2023 Dec; 16(1):240. PubMed ID: 38115063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a tumor immune cell infiltration-related gene signature for recurrence prediction by weighted gene co-expression network analysis in prostate cancer.
    Xie LY; Huang HY; Hao YL; Yu M; Zhang W; Wei E; Gao C; Wang C; Zeng L
    Front Genet; 2023; 14():1067172. PubMed ID: 37007952
    [No Abstract]   [Full Text] [Related]  

  • 17. PPP1R14B is a diagnostic prognostic marker in patients with uterine corpus endometrial carcinoma.
    He K; Wang T; Huang X; Yang Z; Wang Z; Zhang S; Sui X; Jiang J; Zhao L
    J Cell Mol Med; 2023 Mar; 27(6):846-863. PubMed ID: 36824011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene signature and prognostic value of ubiquitination-related genes in endometrial cancer.
    Wang Z; Cheng S; Liu Y; Zhao R; Zhang J; Zhou X; Shu W; Feng D; Wang H
    World J Surg Oncol; 2023 Jan; 21(1):3. PubMed ID: 36611207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHRNB2 represses pancreatic cancer migration and invasion via inhibiting β-catenin pathway.
    Qin C; Li T; Wang Y; Zhao B; Li Z; Li T; Yang X; Zhao Y; Wang W
    Cancer Cell Int; 2022 Nov; 22(1):340. PubMed ID: 36344976
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.